Literature DB >> 10622597

Hepatitis C virus infection: quality of life and side effects of treatment.

G R Foster1.   

Abstract

Studies of the subtle symptoms associated with chronic diseases and detected by quality of life questionnaires are still in their infancy. The techniques used to examine these impairments in well being are still being developed and their use is far from routine. There is a growing body of evidence to show that patients with chronic hepatitis C virus (HCV) without major disease related complications do perceive themselves to be unwell and do have significant changes in their physical and mental well being. These abnormalities cannot be attributed to the mode of acquisition of the infection or to the severity of liver damage. The mechanism of these changes is unknown but the symptoms do remit following successful therapy, indicating that the presence of the virus plays a role in their aetiology. These symptoms require careful evaluation and may be sufficiently severe to justify therapy in the absence of advancing liver damage. Treatment of chronic HCV significantly impairs a patient's quality of life. The decision as to whether an individual patient's symptoms are sufficient to justify therapy in the absence of progressive liver damage is one which must be based on an assessment of the individual's current and future status as well as the individual's ability to tolerate current therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10622597     DOI: 10.1016/s0168-8278(99)80411-5

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  15 in total

Review 1.  Treatment of hepatitis C. The 2002 French consensus.

Authors:  D Dhumeaux; P Marcellin; E Lerebours
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

Review 2.  Hepatitis C: cost of illness and considerations for the economic evaluation of antiviral therapies.

Authors:  John B Wong
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

3.  Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid.

Authors:  Tomasz Laskus; Marek Radkowski; Agnieszka Bednarska; Jeffrey Wilkinson; Debra Adair; Marek Nowicki; Georgia B Nikolopoulou; Hugo Vargas; Jorge Rakela
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

4.  Hepatitis C and poor quality of life: is it the virus or the patient?

Authors:  Ayman A Abdo
Journal:  Saudi J Gastroenterol       Date:  2008-07       Impact factor: 2.485

5.  Psychosocial issues in hepatitis C: a qualitative analysis.

Authors:  E Amy Janke; Sarah McGraw; Guadalupe Garcia-Tsao; Liana Fraenkel
Journal:  Psychosomatics       Date:  2008 Nov-Dec       Impact factor: 2.386

6.  Hepatitis C virus neuroinvasion: identification of infected cells.

Authors:  Jeffrey Wilkinson; Marek Radkowski; Tomasz Laskus
Journal:  J Virol       Date:  2008-11-19       Impact factor: 5.103

7.  Improvement in quality of life measures in patients with refractory hepatitis C, responding to re-treatment with Pegylated interferon alpha -2b and ribavirin.

Authors:  Abraham Mathew; Laurie P Peiffer; Kathy Rhoades; Thomas J McGarrity
Journal:  Health Qual Life Outcomes       Date:  2006-05-12       Impact factor: 3.186

8.  Managing pediatric hepatitis C: current and emerging treatment options.

Authors:  Wikrom Karnsakul; Mary Kay Alford; Kathleen B Schwarz
Journal:  Ther Clin Risk Manag       Date:  2009-08-20       Impact factor: 2.423

9.  Health-related quality of life of Southern Chinese with chronic hepatitis B infection.

Authors:  Elegance T P Lam; Cindy L K Lam; C L Lai; M F Yuen; Daniel Y T Fong; Thomas M K So
Journal:  Health Qual Life Outcomes       Date:  2009-06-05       Impact factor: 3.186

10.  The burden of hepatitis C in Europe from the patients' perspective: a survey in 5 countries.

Authors:  Jeffrey Vietri; Girish Prajapati; Antoine C El Khoury
Journal:  BMC Gastroenterol       Date:  2013-01-17       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.